Mefipic Mango Suspension is used to relieve pain. Pain can be acute (temporary) or chronic (long-lasting). Acute pain is short-term and caused by damage to the tissues of the muscle, bone, or other organs. Chronic pain lasts for a long duration and is caused by pathologies like nerve damage, etc. It helps provide relief from symptoms of muscle pain and dental pain in children. Mefipic Mango Suspension is also used to reduce fever.
Mefipic Mango Suspension is a combination medicine containing two drugs, namely, Mefenamic acid (NSAID) and Paracetamol (antipyretic). Mefenamic acid works by blocking the effect of a chemical known as prostaglandin, responsible for inducing pain and inflammation in our body. Paracetamol lowers the elevated body temperature and mild pain by inhibiting the synthesis of a chemical messenger (prostaglandin) and promoting heat loss (through sweating) that helps reset the hypothalamic thermostat.
Mefipic Mango Suspension may cause certain side effects in your child, such as abdominal pain, cold-like nose symptoms (in children), or diarrhoea (in children). These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your paediatrician. Mefipic Mango Suspension should be taken as advised by your doctor. Do not give more than the prescribed dose of Mefipic Mango Suspension to the child. Mefipic Mango Suspension can be given with or without food. The dose of the medicine will be decided by your paediatrician depending on the type and severity of the infection.
Mefipic Mango Suspension is intended for pediatric use only. Avoid giving Mefipic Mango Suspension to your child if she/he is allergic to antibiotics. Keep your doctor informed about your child’s health condition, including his current medications and medical history, to rule out any side effects/interactions. Before administration, inform your child’s doctor about liver and kidney disease. Mefipic Mango Suspension is not recommended for use in children below six months of age as its safety and efficacy are not established.